November 15, 2024

First Aid Guidelines See Major Overhaul After 14 Years

None of the 179 first aid recommendations in the 2024 AHA/Red Cross guidelines achieved Level A evidence support, highlighting critical research gaps in foundational emergency care practices.

Conexiant

November 13, 2024

COVID-19 Tied to Higher Myocarditis Risk

Conexiant

November 13, 2024

AHA/AAP Update Pediatric Drowning Response Protocols

When respiratory arrest is corrected by rescue breathing that interrupts the drowning process, the death rate is 44% compared to 93% when full CPR is needed—a stark difference highlighting the critical importance of early intervention in pediatric drowning cases.

Conexiant

November 11, 2024

AF Burden Trends Linked to Stroke Risk

Temporal AF burden trends offer a novel edge in stroke prediction, outperforming traditional risk scores with a predictive AUC of 0.726 for ischemic events, a new study finds.

Conexiant

November 11, 2024

Cardiac Patients Sought Sex Advice, Found Silence

While 76% of cardiac patients reported sexual health affecting their mood and well-being, only 5% received counseling on the topic, according to new survey data presented at AHA Scientific Sessions 2024.

Conexiant

November 05, 2024

High COVID-19 Burden Linked to More Hospital AEs

A recent study found a large increase in hospital adverse events during weeks with a high COVID-19 burden, with the impact hitting both COVID-19 and non-COVID-19 patients.

Conexiant

November 04, 2024

Study: Heat Increases Hypoglycemia Risk in T2D

A recent study reveals the impact of ambient temperature on adverse health outcomes in patients with type 2 diabetes, with significant associations found between temperature and serious hypoglycemia, diabetic ketoacidosis, and sudden cardiac arrest.

Conexiant

November 01, 2024

Quitting Smoking: How Long Until CVD Risk Drops

Heavy ex-smokers face elevated CVD risk up to 25 years post-cessation, highlighting cumulative smoking burden's impact on cardiovascular health.

Conexiant

October 31, 2024

Vericiguat Trial Aims to Reduce HF Readmissions

VICTOR trial examines vericiguat’s impact on cardiovascular death and heart failure hospitalizations in 6,000 stable HFrEF patients receiving quadruple therapy.

Conexiant